HuGE Literature Finder
Records
1
-
12
| HLA-G 3' untranslated region variants +3187G/G, +3196G/G and +3035T define diametrical clinical status and disease outcome in epithelial ovarian cancer. Scientific reports 2019 Apr 9 (1): 5407. Schwich Esther, Rebmann Vera, Michita Rafael Tomoya, Rohn Hana, Voncken Jan Willem, Horn Peter A, Kimmig Rainer, Kasimir-Bauer Sabine, Buderath Pa |
| HLA superfamily assignment is a predictor of immune response to cancer testis antigens and survival in ovarian cancer. Gynecologic oncology 2016 Apr . Szender J Brian, Eng Kevin H, Matsuzaki Junko, Miliotto Anthony, Gnjatic Sacha, Tsuji Takemasa, Odunsi Kun |
| Relevance of HLA-DP/DQ and ICAM-1 SNPs among Ovarian Cancer Patients. Frontiers in immunology 2016 7 202. Ghazy Amany A, El-Etreby Nour |
| Human leukocyte antigen-E alleles and expression in patients with serous ovarian cancer. Cancer science 2015 May 106 (5): 522-8. Zheng Hui, Lu Renquan, Xie Suhong, Wen Xuemei, Wang Hongling, Gao Xiang, Guo L |
| Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with epithelial ovarian cancer. Human immunology 2014 Jun 75 (6): 508-13. Giebel Sebastian, Boratyn-Nowicka Agnieszka, Karabon Lidia, Jedynak Anna, Pamula-Pilat Jolanta, Tecza Karolina, Kula Dorota, Kowal Monika, Frydecka Irena, Grzybowska E |
| Correlation of HLA-A02* genotype and HLA class I antigen down-regulation with the prognosis of epithelial ovarian cancer. Cancer immunology, immunotherapy : CII 2012 Aug 61 (8): 1243-53. Andersson Emilia, Villabona Lisa, Bergfeldt Kjell, Carlson Joseph W, Ferrone Soldano, Kiessling Rolf, Seliger Barbara, Masucci Giuseppe |
| The common Scandinavian human leucocyte antigen ancestral haplotype 62.1 as prognostic factor in patients with advanced malignant melanoma. Cancer immunology, immunotherapy : CII 2009 Oct 58 (10): 1599-608. Helgadottir Hildur, Andersson Emilia, Villabona Lisa, Kanter Lena, van der Zanden Henk, Haasnoot Geert W, Seliger Barbara, Bergfeldt Kjell, Hansson Johan, Ragnarsson-Olding Boel, Kiessling Rolf, Masucci Giuseppe Valenti |
| Analysis of HLA class I-II haplotype frequency and segregation in a cohort of patients with advanced stage ovarian cancer. Tissue antigens 2007 Sep 70 (3): 205-13. Gamzatova Z, Villabona L, van der Zanden H, Haasnoot G W, Andersson E, Kiessling R, Seliger B, Kanter L, Dalianis T, Bergfeldt K, Masucci G |
| HLA-class II haplotype associations with ovarian cancer. International journal of cancer. Journal international du cancer 2006 Dec 119 (12): 2980-5. Kübler Kirsten, Arndt Peter F, Wardelmann Eva, Krebs Dieter, Kuhn Walther, van der Ven Katr |
| Identification of HLA-DQalpha and -DRbeta residues associated with susceptibility and protection to epithelial ovarian cancer. Human immunology 2005 May 66 (5): 554-62. Monos Dimitri S, Pappas John, Magira Eleni E, Gaughan John, Aplenc Richard, Sakkas Lazaros, Freedman Ralph, Reveille John D, Platsoucas Chris |
| Correlation between HLA-A2 gene frequency, latitude, ovarian and prostate cancer mortality rates. Medical oncology (Northwood, London, England) 2004 21 (1): 49-52. De Petris Luigi, Bergfeldt Kjell, Hising Christina, Lundqvist Andreas, Tholander Bengt, Pisa Pavel, van der Zanden Henk G M, Masucci Giusep |
| [Expression of the major histocompability complex HLA-A2 gene in ovarian cancer]. Arkhiv patologii 0 68 (6): 3-6. Kostiuchek D F, Anichkov N M, Gamzatova Z Kh, Masucchi G V, Bergfedt K, Villabona |
- Page last reviewed:Jul 25, 2022
- Page last updated:Sep 22, 2022
- Content source: